Allscripts Healthcare Solutions, Inc. MDRX
We take great care to ensure that the data presented and summarized in this overview for ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding MDRX
View all-
Mason Capital Management LLC New York, NY2.5MShares$27.1 Million34.98% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA2.46MShares$26.7 Million0.1% of portfolio
-
Tekla Capital Management LLC429KShares$4.65 Million0.21% of portfolio
-
Smith, Graham & Co., Investment Advisors, LP352KShares$3.82 Million0.43% of portfolio
-
Colony Group LLC Boston, MA155KShares$1.68 Million0.03% of portfolio
-
Kennedy Capital Management, Inc. St Louis, MO138KShares$1.5 Million0.03% of portfolio
-
Putnam Investments LLC Boston, MA111KShares$1.21 Million0.0% of portfolio
-
Teachers Retirement System Of The State Of Kentucky Frankfort, KY36KShares$390,3610.0% of portfolio
-
Sterling Capital Management LLC Charlotte, NC33.3KShares$361,0880.0% of portfolio
-
Virginia Retirement Systems Et Al Richmond, VA27.4KShares$297,2900.0% of portfolio
Latest Institutional Activity in MDRX
Top Purchases
Top Sells
About MDRX
Allscripts Healthcare Solutions, Inc., together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
Insider Transactions at MDRX
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 03
2024
|
Tejal Vakharia SVP General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,223
-0.38%
|
$11,007
$9.61 P/Share
|
May 31
2024
|
Carol J Zierhoffer |
BUY
Grant, award, or other acquisition
|
Direct |
42,106
+33.29%
|
-
|
May 31
2024
|
Jonathan Judge |
BUY
Grant, award, or other acquisition
|
Direct |
42,106
+19.43%
|
-
|
May 31
2024
|
David B Stevens |
BUY
Grant, award, or other acquisition
|
Direct |
42,106
+36.11%
|
-
|
May 31
2024
|
Lisa Hammond SVP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
52,632
+30.51%
|
-
|
May 31
2024
|
Susan Rodriguez |
BUY
Grant, award, or other acquisition
|
Direct |
42,106
+50.0%
|
-
|
May 31
2024
|
Elizabeth Ann Altman |
BUY
Grant, award, or other acquisition
|
Direct |
42,106
+35.16%
|
-
|
May 31
2024
|
Thomas Langan CEO |
BUY
Grant, award, or other acquisition
|
Direct |
157,895
+32.24%
|
-
|
May 31
2024
|
Greg Garrison Execuitive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
6,179
-7.57%
|
$55,611
$9.5 P/Share
|
May 31
2024
|
Greg Garrison Execuitive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
21,053
+20.5%
|
-
|
May 31
2024
|
Leland Westerfield CFO |
BUY
Grant, award, or other acquisition
|
Direct |
105,264
+50.0%
|
-
|
May 31
2024
|
Tejal Vakharia SVP General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
63,158
+16.39%
|
-
|
May 25
2024
|
Lisa Hammond SVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,540
-2.24%
|
$10,780
$7.55 P/Share
|
May 03
2024
|
Lisa Hammond SVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,105
-2.97%
|
$14,735
$7.7 P/Share
|
May 03
2024
|
Tejal Vakharia SVP General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,169
-1.21%
|
$22,183
$7.7 P/Share
|
May 02
2024
|
Thomas Langan CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,893
-1.08%
|
$13,251
$7.8 P/Share
|
May 01
2024
|
Thomas Langan CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,354
-5.05%
|
$65,478
$7.82 P/Share
|
May 01
2024
|
Tejal Vakharia SVP General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,301
-1.61%
|
$30,107
$7.82 P/Share
|
Apr 01
2024
|
Lisa Hammond SVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
193
-0.27%
|
$1,351
$7.8 P/Share
|
Apr 01
2024
|
Thomas Langan CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,709
-1.51%
|
$39,963
$7.8 P/Share
|
Last 12 Months Summary
Open market or private purchase | 10.2M shares |
---|---|
Grant, award, or other acquisition | 778K shares |
Payment of exercise price or tax liability | 48.6K shares |
---|